# 2025-21184: Lab Named 'Eli-Elsohly' Wants to Make Bulk Controlled Drugs

2025-21184, Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-11-26, effective 2026-01-26 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-21184
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-21184
- Title: Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 54377
- Published: 2025-11-26
- Effective: 2026-01-26
- Comments close: 2026-01-26
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Lab Named 'Eli-Elsohly' Wants to Make Bulk Controlled Drugs

## Summary

Eli-Elsohly Laboratories wants to become a big-time maker of certain controlled substances like marijuana extracts and some strong medicines. People and companies involved with these drugs can share their thoughts or ask for a hearing by January 26, 2026. This move could impact how these substances are produced and tracked, but no direct costs are mentioned yet.

## Abstract

Eli-Elsohly Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-21184 on federalregister.gov](https://www.federalregister.gov/documents/2025/11/26/2025-21184/bulk-manufacturer-of-controlled-substances-application-eli-elsohly-laboratories)
- [2025-21184 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-11-26/pdf/2025-21184.pdf)

## Related
- [Previous: 2025-21183, Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company](https://policyrisk.com/federal-register/2025-21183)
- [Next: 2025-21185, Bulk Manufacturer of Controlled Substances Application: Siegfried Grafton, Inc.](https://policyrisk.com/federal-register/2025-21185)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-21184 (as of 2026-06-08).
